Optimal screening interval for men with low baseline prostate-specific antigen levels (≤1.0 ng/mL) in a prostate cancer screening program
Crossref DOI link: https://doi.org/10.1007/s00345-016-1894-3
Published Online: 2016-07-15
Published Print: 2017-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Urata, Satoko
Kitagawa, Yasuhide http://orcid.org/0000-0003-4356-8686
Matsuyama, Satoko
Naito, Renato
Yasuda, Kenji
Mizokami, Atsushi
Namiki, Mikio
License valid from 2016-07-15